# Semnur Pharmaceuticals, Inc.: filings

SMNR · OTC · CIK 1913577 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/smnr.md) · [Financials](/companies/smnr/financials.md) · [Filings](/companies/smnr/filings.md) · [Insiders](/companies/smnr/insiders.md)

## Reports and events: 74 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 45, 425 30, 10-Q 14, 3 14, SC 13G/A 12, SC 13G 11, CORRESP 10, UPLOAD 8, 424B3 7, NT 10-Q 7, S-4/A 7, 4 6, SCHEDULE 13G/A 5, 10-K 4, DEF 14A 4, EFFECT 4, S-1/A 4, PRE 14A 3, DEFA14A 2, S-1 2, S-8 2, 25-NSE 1, 8-A12B 1, 8-K/A 1, ARS 1, CERT 1, DEFM14A 1, DEFR14A 1, NT 10-K 1, POS AM 1, PRER14A 1, S-4 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 16:54 ET | [10-Q](/filings/0001193125-26-342594.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342594 |
| 2026-07-07 | 10:38 ET | [8-K](/filings/0001193125-26-297085.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-297085 |
| 2026-06-25 | 17:03 ET | [8-K](/filings/0001193125-26-283007.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-283007 |
| 2026-05-13 | 17:02 ET | [10-Q](/filings/0001193125-26-221896.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221896 |
| 2026-04-30 | 16:50 ET | [DEF 14A](/filings/0001193125-26-197655.md) | Proxy statement, period 2026-06-25 | 0001193125-26-197655 |
| 2026-04-23 | 16:08 ET | [8-K](/filings/0001193125-26-173690.md) | 1.02 Termination of a material agreement | 0001193125-26-173690 |
| 2026-03-17 | 16:13 ET | [8-K](/filings/0001193125-26-110816.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-110816 |
| 2026-02-27 | 16:12 ET | [10-K](/filings/0001193125-26-082642.md) | Annual report, period 2025-12-31 | 0001193125-26-082642 |
| 2025-12-19 | 16:07 ET | [S-1/A](/filings/0001193125-25-326813.md) | Registration statement, amended | 0001193125-25-326813 |
| 2025-12-03 | 16:20 ET | [8-K](/filings/0001193125-25-306757.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-306757 |
| 2025-11-12 | 16:06 ET | [10-Q](/filings/0001193125-25-277536.md) | Quarterly report, period 2025-09-30 | 0001193125-25-277536 |
| 2025-10-21 | 16:21 ET | [S-1](/filings/0001193125-25-245178.md) | Registration statement | 0001193125-25-245178 |
| 2025-09-26 | 16:06 ET | [8-K](/filings/0001193125-25-220455.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-220455 |
| 2025-09-04 | 17:40 ET | [8-K](/filings/0001213900-25-084180.md) | 5.07 Shareholder vote results | 0001213900-25-084180 |
| 2025-08-22 | 20:27 ET | [8-K](/filings/0001213900-25-079504.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-079504 |
| 2025-08-15 | 07:50 ET | [10-Q](/filings/0001213900-25-077047.md) | Quarterly report, period 2025-06-30 | 0001213900-25-077047 |
| 2025-08-11 | 07:00 ET | [8-K](/filings/0001213900-25-073907.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-073907 |
| 2025-07-28 | 16:40 ET | [8-K](/filings/0001213900-25-068263.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-068263 |
| 2025-07-11 | 16:30 ET | [8-K](/filings/0001213900-25-063294.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-063294 |
| 2025-06-12 | 21:38 ET | [8-K](/filings/0001213900-25-053576.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053576 |
| 2025-05-16 | 16:12 ET | [10-Q](/filings/0001213900-25-044889.md) | Quarterly report, period 2025-03-31 | 0001213900-25-044889 |
| 2025-05-12 | 19:46 ET | [8-K](/filings/0001213900-25-041653.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-041653 |
| 2025-04-22 | 17:10 ET | [8-K](/filings/0001213900-25-034254.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-034254 |
| 2025-04-16 | 21:20 ET | [8-K](/filings/0001213900-25-032299.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-032299 |
| 2025-04-09 | 20:30 ET | [8-K](/filings/0001213900-25-030048.md) | 3.01 Delisting notice | 0001213900-25-030048 |
| 2025-04-02 | 17:49 ET | [10-K](/filings/0001213900-25-027319.md) | Annual report, period 2024-12-31 | 0001213900-25-027319 |
| 2025-03-27 | 17:13 ET | [DEF 14A](/filings/0001013762-25-003461.md) | Proxy statement, period 2025-04-10 | 0001013762-25-003461 |
| 2025-03-12 | 18:39 ET | [8-K](/filings/0001213900-25-022858.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-022858 |
| 2025-02-11 | 16:12 ET | [8-K](/filings/0001213900-25-012213.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-012213 |
| 2025-01-08 | 16:20 ET | [8-K](/filings/0001213900-25-002085.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-002085 |
| 2024-12-11 | 17:02 ET | [8-K](/filings/0001213900-24-107941.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-107941 |
| 2024-11-19 | 17:03 ET | [10-Q](/filings/0001213900-24-100217.md) | Quarterly report, period 2024-09-30 | 0001213900-24-100217 |
| 2024-11-12 | 16:15 ET | [8-K](/filings/0001213900-24-096807.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-096807 |
| 2024-10-11 | 17:16 ET | [8-K](/filings/0001213900-24-087340.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-087340 |
| 2024-10-07 | 16:30 ET | [8-K](/filings/0001213900-24-085921.md) | 3.01 Delisting notice | 0001213900-24-085921 |
| 2024-09-12 | 17:45 ET | [8-K](/filings/0001213900-24-077790.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077790 |
| 2024-09-05 | 20:55 ET | [8-K](/filings/0001213900-24-075736.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-075736 |
| 2024-08-19 | 17:27 ET | [10-Q](/filings/0001213900-24-070799.md) | Quarterly report, period 2024-06-30 | 0001213900-24-070799 |
| 2024-08-09 | 16:58 ET | [8-K](/filings/0001213900-24-067209.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-067209 |
| 2024-07-17 | 14:45 ET | [8-K](/filings/0001213900-24-062099.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-24-062099 |
| 2024-07-10 | 16:56 ET | [8-K](/filings/0001213900-24-060537.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-060537 |
| 2024-07-05 | 16:03 ET | [8-K](/filings/0001213900-24-059541.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-059541 |
| 2024-06-28 | 17:20 ET | [DEF 14A](/filings/0001213900-24-057300.md) | Proxy statement, period 2024-07-10 | 0001213900-24-057300 |
| 2024-06-27 | 14:42 ET | [8-K](/filings/0001213900-24-056571.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-056571 |
| 2024-05-22 | 20:03 ET | [10-Q](/filings/0001213900-24-045702.md) | Quarterly report, period 2024-03-31 | 0001213900-24-045702 |
| 2024-04-01 | 16:41 ET | [10-K](/filings/0001213900-24-028809.md) | Annual report, period 2023-12-31 | 0001213900-24-028809 |
| 2024-02-27 | 16:30 ET | [8-K](/filings/0001213900-24-017542.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-24-017542 |
| 2024-01-10 | 21:40 ET | [8-K](/filings/0001213900-24-002430.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-002430 |
| 2023-12-29 | 16:02 ET | [8-K](/filings/0001213900-23-099880.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-099880 |
| 2023-11-20 | 16:44 ET | [8-K](/filings/0001213900-23-088773.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-088773 |

Page 1 of 2. [Older](/companies/smnr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.